News

Eine App für Krebspatienten: Innoplexus stellt CURIA vor

Österreichische Gesellschaft für Pharmazeutische Medizin erweitert Vorstand

Nabriva Therapeutics Receives Complete Response Letter from FDA on NDA for CONTEPO™ (fosfomycin) for injection

Coronavirus: PHARMIG und ÖVIH unterstützen EU-Impfstoffstrategie

APEPTICO has been nominated one of the most innovative companies in Austria in the categories medicines and organic chemistry

APEPTICO has been nominated one of the most innovative companies in Austria in the categories medicines and organic chemistry

MSD schließt Übernahme von Themis ab

HOOKIPA Announces Positive Phase 2 Interim Safety and Immunogenicity Results for its CMV Vaccine Candidate HB 101

ETIHAD AIRWAYS PARTNERS WITH MEDICUS AI TO LAUNCH COVID-19 RISK ASSESSMENT TOOL ACROSS DIGITAL PLATFORMS

The Lancet Neurology publishes positive results of AFFiRiS’ Phase 1 trial with PD01A in Parkinson’s disease patients

CeMM receives the special prize of the Austrian “Innovation Awards 2020/2021” in organic chemistry

Wer gut hören will, braucht zwei Ohren

HOOKIPA Announces Changes to its Board of Directors – Resignation of Sander van Deventer

Valneva and Bavarian Nordic Announce Marketing and Distribution Partnership

Neuer Therapieansatz in der Behandlung von Darmkrebs identifiziert

Houskapreis der B&C Privatstiftung: Rolf Breinbauer neu im Fachbeirat

Hygiene Austria LP GmbH schließt Schutzmasken-Deal mit Würth

HOOKIPA Announces FDA Clearance of its IND Application for HB-202/201 Clinical Trial to Treat HPV-Positive Cancers

Digitale Hilfe für Betreuung und Pflege

Chemie, die Krebszellen überlistet